Browse

Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia

Cited 12 time in Web of Science Cited 15 time in Scopus
Authors
Kim, Jong-Hoon; Kim, Seong-Youn; Ahn, Yong Min; Kim, Yong Sik
Issue Date
2005-11-29
Publisher
Elsevier
Citation
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):301-5. Epub 2005 Nov 23.
Keywords
AdultAntipsychotic Agents/*therapeutic useAttitudeChi-Square DistributionClozapine/*therapeutic useDrug Therapy, CombinationFemaleHumansMaleMultivariate AnalysisOutpatients/*psychologyPsychiatric Status Rating ScalesQuestionnairesRisperidone/*therapeutic useSchizophrenia/*drug therapy*Schizophrenic PsychologyTime Factors
Abstract
The purpose of the present study was to compare the subjective response and attitude towards antipsychotic treatment between schizophrenic patients receiving clozapine and those receiving risperidone. Ninety-four outpatients who had been on a stable drug dosage were evaluated (clozapine group: n=57, mean dose=254.1 mg/day; risperidone group: n=37, mean dose=3.0 mg/day). Subjective response to antipsychotic treatment was assessed using the Drug Attitude Inventory (DAI). The two treatment groups had a positive total mean score, indicating that both groups had a positive subjective view of drug treatment. The proportion of subjects who had a positive total score was not different between the two groups. In subscale scores, multivariate analysis revealed that clozapine group tended to have a higher score on the subjective positive response subscale (P=0.06). The scores of subjective negative response or attitude to medication subscales were not different between groups. In conclusion, there was no marked difference between stabilized outpatients taking clozapine and risperidone in terms of subjective response and attitude towards antipsychotic treatment. Considering that subjects treated with clozapine were treatment resistant patients, equal DAI score might indicate a more favorable subjective experience of clozapine. Further prospective studies on subjective response to various atypical agents are required to obtain valuable insight into how best to use these drugs from the patient's perspective.
ISSN
0278-5846 (Print)
Language
English
URI
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBR-4HMNG91-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=29be707aa3bbad07cf021c3e25cc5338

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16309807

http://hdl.handle.net/10371/24032
DOI
https://doi.org/10.1016/j.pnpbp.2005.10.006
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Psychiatry (정신과학전공)Journal Papers (저널논문_정신과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse